Inflation Rate Projected to Reach 6 in Second Quarter Top Economic Forecasters Say Bitcoin Slips to 74500 Set for Weekly Decline Amid Geopolitical Jitters How to Minimize Tax on a 300000 Family Trust Distribution Strategies for Beneficiaries University of Manchester to Offer Universal Work Placements for All Undergraduates White House Highlights Soybean and Rare Earth Deals After TrumpXi Summit as China Signals Potential Tariff Reductions Berkshire Hathaways Latest Stock Sales Signal Strategic Shift Yahoo Finance Reports RXO Q1 2026 Earnings Narrowing Loss Beats Expectations Stock Edges Higher Atlanticus Holdings ATLC Q1 2026 Earnings EPS Surges Past Estimates with 258 Beat Grand Canyon Education Inc LOPE Q1 2026 Earnings EPS Surpasses Estimates Amidst Steady Operations SYK Q1 2026 Earnings EPS Misses Estimates Shares Slide 226 BOX Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Pullback Iron Horse Acquisitions II Corp IRHO Holds Steady at 1005 A SPAC Poised for Potential Breakout Bon Natural Life Limited BON Declines Slightly as Stock Hovers Near Key 12 Support Zone Greif Inc GEF Edges Lower as Stock Consolidates Near Key Support Levels Fennec Pharmaceuticals FENC Gains 17 as Shares Bounce Off Support Key Levels in Focus Flaherty Crumrine Dynamic Preferred and Income Fund DFP Edges Higher in Measured Trading Automatic Data Processing ADP Receives Equal Weight Rating from Analyst with 214 Price Target MED Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise 1RT Acquisition Corp Units ONCHU Holds Steady at 1032 Amid Quiet Trading BJs Wholesale Club Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips Slightly Barclays Raises Price Target on JFrog to 75 Maintains Overweight Rating Corebridge Financial Q1 2026 Earnings EPS Falls Slightly Short of Expectations as Shares Edge Higher IDXX Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue Backdrop CCAP Q1 2026 Earnings Slight EPS Miss as Business Development Firm Maintains Steady Performance BayCom Corp BCML Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Uptick Telomir Pharmaceuticals Q4 2025 Earnings WiderthanExpected Loss as Revenue Remains Absent